Physician profile
Michael Leonard Renda
NPI 1104239946
$90,461.15
in general payments reported to CMS, 2019-2025
19 companies · $44K in 2025
The $44K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $360 · 2021: $739 · 2022: $4,774 · 2023: $17K · 2024: $23K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $39K · Consulting Fee: $16K · Education: $15K · Travel and Lodging: $9,388 · Food and Beverage: $5,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $38,700.00 |
| Consulting Fee | $16,157.50 |
| Education | $14,997.83 |
| Travel and Lodging | $9,388.07 |
| Food and Beverage | $5,219.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $44,544.83 | 2021-2025 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $37,780.46 | 2022-2025 | Ribfix Blu Advantage, Advantagerib, Sternalock Blu System |
| Ethicon US, LLC | $3,418.53 | 2023-2025 | Harmonic, Evarrest, Echelon; Endopath |
| Atricure, INC. | $1,222.65 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Tela Bio, INC. | $771.52 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $446.54 | 2019-2022 | |
| Becton, Dickinson and Company | $445.43 | 2024 | Phasix Mesh |
| Abbvie INC. | $287.77 | 2023-2025 | |
| Medtronic, INC. | $217.54 | 2022-2023 | Mycarelink |
| Kci USA, INC. | $195.54 | 2021-2023 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, V.A.C. Veraflo |
| Galderma Laboratories, L.P. | $188.15 | 2022 | |
| Acera Surgical, INC. | $161.08 | 2023 | Restrata Wound Matrix |
| Silk Road Medical, INC. | $155.43 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medical Device Business Services, INC. | $153.81 | 2025 | Harmonic |
| Kerecis Limited | $151.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $125.44 | 2021 | |
| Teleflex LLC | $124.42 | 2020 | |
| Kls-Martin L.P. | $54.48 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $15.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Renda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.